当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3296848
自主品牌
已选条件
-
T2303Afatinib阿法替尼；BIBW2992
Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5/0.4/10/14/1 nM for EGFRwt, EGFR (L858R), EGFR (L858R/T790M), HER2, and HER4, respectively.
价 格：￥电议型 号：T2303产 地：中国大陆
-
T21312Afatinib阿法替尼；Afatinib free base；BIBW 2992
Afatinib is an irreversible inhibitor of EGFR family (EGFR-wt, EGFR-L858R, EGFR-L858R/T790M and HER2 with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM , respectively).
价 格：￥电议型 号：T21312产 地：中国大陆
-
T1773Afatinib DimaleateBIBW2992；BIBW 2992MA2；Afatinib；马来酸阿法替尼；双马来酸盐阿法替尼；Afatinib (BIBW2992) Dimaleate
Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.
价 格：￥电议型 号：T1773产 地：中国大陆
-
T1773Afatinib DimaleateAfatinib Dimaleate,Afatinib,BIBW2992
Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.
价 格：￥电议型 号：T1773产 地：美洲
-
T21312Afatinib free baseAfatinib free base,BIBW 2992,
Afatinib is an irreversible inhibitor of EGFR family (EGFR-wt, EGFR-L858R, EGFR-L858R/T790M and HER2 with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM , respectively).
价 格：￥电议型 号：T21312产 地：美洲
-
T2303AfatinibAfatinib,BIBW2992,
Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5/0.4/10/14/1 nM for EGFRwt, EGFR (L858R), EGFR (L858R/T790M), HER2, and HER4, respectively.
价 格：￥电议型 号：T2303产 地：美洲
-
T72912(R)-Afatinib；化合物 (R)-Afatinib(R)-BIBW 2992；(R)-BIBW 2992
(R)-Afatinib ((R)-BIBW 2992), an isomer of Afatinib, is a potent, orally administered, irreversible inhibitor targeting the ErbB family (EGFR and HER2) with IC50 values of 0.5 nM for EGFR wt, 0.4 nM for EGFR L858R, 10 nM for EGFR L858R/T790M, and 14 nM for HER2. It holds potential for research into esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC), and gastric cancer [1].
价 格：￥电议型 号：T72912产 地：中国大陆
-
T26803Bibw 22；化合物 T26803Bibw22|||Bibw-22；Bibw22|||Bibw-22
Bibw 22 is a bifunctional modulator of P-glycoprotein and nucleoside transport.
价 格：￥电议型 号：T26803产 地：中国大陆
-
T2303(S)-Afatinib；阿法替尼BIBW2992；BIBW2992|||阿法替尼
(S)-Afatinib (BIBW2992) is an irreversible EGFR family inhibitor with IC50s of 0.5/0.4/10/14/1 nM for EGFRwt, EGFR (L858R), EGFR (L858R/T790M), HER2, and HER4, respectively.
价 格：￥电议型 号：T2303产 地：中国大陆
-
T21312Afatinib；阿法替尼Afatinib free base|||BIBW 2992；阿法替尼|||Afatinib free base|||BIBW 2992
Afatinib (BIBW 2992) is an irreversible inhibitor of EGFR family (EGFR-wt, EGFR-L858R, EGFR-L858R/T790M and HER2 with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM , respectively).
价 格：￥电议型 号：T21312产 地：中国大陆
-
T1773Afatinib Dimaleate；双马来酸盐阿法替尼BIBW2992|||Afatinib|||BIBW 2992MA2|||Afatinib (BIBW2992) Dimaleate；马来酸阿法
Afatinib Dimaleate (BIBW 2992MA2) is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.
价 格：￥电议型 号：T1773产 地：中国大陆
